Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 18 for:    wassermann, eric

Functional Connectivity as a Biomarker of rTMS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03050801
Recruitment Status : Recruiting
First Posted : February 13, 2017
Last Update Posted : January 3, 2019
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Neurological Disorders and Stroke (NINDS) )

Brief Summary:

Background:

Traumatic brain injury (TBI) damages the connections between brain cells. This can lead to problems like memory loss. Repetitive transcranial magnetic stimulation (rTMS) can help improve connections between brain areas in healthy people. Researchers want to see if it can be useful in patients with memory problems after TBI.

Objective:

To see how repetitive transcranial magnetic stimulation can be used to improve the connections between parts of the brain and whether this will lead to changes in memory.

Eligibility:

Adults 18-50 years old with TBI who can speak and write in English.

Healthy volunteers the same age and English ability.

Design:

Participants will be screened with a neurological exam and may have a urine pregnancy test.

Participants with TBI will have 7-15 visits. Healthy volunteers will have 2-8.

At the visits, participants will have all or some of the following:

  • MRI for about 1 hour. They will lie in a machine that takes pictures in a magnetic field. They will do some memory tasks.
  • Memory and attention tasks with pictures and with a computer
  • Questions about their mental state and well-being
  • TMS: A wire coil is held on the scalp and a short electrical current passes through it. Participants will hear a click and feel a pulling or twitch. They may be asked to make simple movements. rTMS is repeated magnetic pulses in short bursts. They will have this for about 20 minutes.

A week after the last visit, some participants will return for a memory test.


Condition or disease Intervention/treatment Phase
Traumatic Brain Injury Device: rTMS Phase 1 Phase 2

Detailed Description:

Objective: To use resting state functional connectivity (FC) as a biomarker of synaptic modulation by repetitive transcranial magnetic stimulation (rTMS) in paradigms intended to improve memory and learning and to pilot one such paradigm for improving memory in traumatic brain injury (TBI) patients. Ancillary outcomes include the effects of rTMS on the explicit and implicit memory systems and the potential effects of manipulating one system on the other.

Study population: Healthy adult volunteers and patients with TBI

Design: The study contains 3 experiments. Experiment 1 is designed to establish the number of rTMS sessions required to produce a meaningful change in resting parietohippocampal FC in healthy subjects. Experiment 2 will apply this information to an experiment aimed at enhancing fronto-striatal FC and, as a secondary outcome, enhancing implicit memory. This intervention will be contrasted with parietal stimulation and a negative control condition (vertex stimulation) in a between-groups design. In Experiment 3, we will adapt a paradigm used by others in healthy subjects to amnestic TBI patients in an effort to enhance parieto-hippocampal FC and, as a secondary outcome, explicit memory. This will be compared to negative control (vertex) stimulation in a within-subjects design

Outcome measures: The primary outcome measure is the change in FC produced by serially applied rTMS. Secondary measures will be changes in explicit and implicit memory performance. We will explore whether white matter integrity predicts changes in FC in healthy subjects and patients.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 123 participants
Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Functional Connectivity as a Biomarker of rTMS
Actual Study Start Date : March 24, 2017
Estimated Primary Completion Date : February 1, 2020
Estimated Study Completion Date : February 1, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Memory

Arm Intervention/treatment
Experimental: Frontal rTMS
Prefrontal rTMS
Device: rTMS
Altering the connectivity of trans-synaptic pathways

Experimental: Parietal rTMS
Parietal rTMS
Device: rTMS
Altering the connectivity of trans-synaptic pathways

Active Comparator: Vertex rTMS
Vertex rTMS
Device: rTMS
Altering the connectivity of trans-synaptic pathways




Primary Outcome Measures :
  1. Functional connectivity [ Time Frame: End Treatment ]

Secondary Outcome Measures :
  1. Memory tests [ Time Frame: 1hr, 1wk ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria
  • INCLUSION CRITERIA:

Healthy individuals in Experiments 1 and 2.

Age 18-50 (inclusive)

- English speaking and writing

Patients in Experiment 3

  • Age 18-50 (inclusive)
  • English speaking and writing
  • History of mild to moderate TBI
  • Performance 1 standard deviation below age-adjusted population norms on the

CVLT-2 within the past year from the date of visit.

EXCLUSION CRITERIA:

Healthy subjects

  • Any current major neurological or psychiatric disorder such as (but not limited to) stroke, Parkinson disease, Alzheimer disease, schizophrenia or major depression
  • History of seizure
  • Medications acting on the central nervous system
  • Ferromagnetic metal in the cranial cavity or eye, implanted neural stimulator, cochlear implant, or ocular foreign body
  • Implanted cardiac pacemaker or auto-defibrillator or pump
  • Non-removable body piercing
  • Claustrophobia
  • Inability to lie supine for 1 hour
  • Pregnancy, nursing, or plans to become pregnant during the study.
  • Members of the NINDS Behavioral Neurology Unit (BNU)
  • For Experiment 2: Participation in Experiment 1

TBI Patients

  • Any current major neurological or psychiatric disorder unrelated to TBI, such as (but not limited to) stroke, Parkinson disease, Alzheimer disease, schizophrenia or major depression.
  • History of seizure
  • Inability to give informed consent
  • Ferromagnetic metal in the cranial cavity or eye, implanted neural stimulator, cochlear implant, or ocular foreign body
  • Implanted cardiac pacemaker or auto-defibrillator or pump
  • Non-removable body piercing
  • Claustrophobia
  • Inability to lie supine for 1 hour
  • Pregnancy, nursing, or plans to become pregnant during the study.
  • Members of the NINDS Behavioral Neurology Unit (BNU)
  • For Experiment 2: Participation in Experiment 1

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03050801


Contacts
Layout table for location contacts
Contact: Jack A Reeves (301) 496-0220 jack.reeves@nih.gov

Locations
Layout table for location information
United States, Maryland
National Institutes of Health Clinical Center Recruiting
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov   
Sponsors and Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Investigators
Layout table for investigator information
Principal Investigator: Eric M Wassermann, M.D. National Institute of Neurological Disorders and Stroke (NINDS)

Additional Information:
Publications:
Layout table for additonal information
Responsible Party: National Institute of Neurological Disorders and Stroke (NINDS)
ClinicalTrials.gov Identifier: NCT03050801     History of Changes
Other Study ID Numbers: 170055
17-N-0055
First Posted: February 13, 2017    Key Record Dates
Last Update Posted: January 3, 2019
Last Verified: December 17, 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: No

Keywords provided by National Institutes of Health Clinical Center (CC) ( National Institute of Neurological Disorders and Stroke (NINDS) ):
Explicit Memory
Implicit Memory
Memory Disorder

Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Injuries
Brain Injuries, Traumatic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries